Add Yahoo as a preferred source to see more of our stories on Google. Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s ...

New York, United States , June 13, 2024 (GLOBE NEWSWIRE) -- The Global Empty Capsules Market Size is to Grow from USD 3.17 Billion in 2023 to USD 7.53 Billion by 2033, at a Compound Annual Growth Rate ...

The empty capsules market is set for growth due to increasing demand for nutraceuticals from an aging population and health-conscious millennials, alongside advancements in capsule tech and rising ...

The enteric empty capsules market is poised for growth due to strategic supply chain localization, rising gastrointestinal disease cases, and increased vegetarian capsule demand. Opportunities lie in ...

Westford, USA, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Empty Capsules Market size was valued at USD 2.89 billion in 2023 to USD 4.96 billion by 2031, growing at a CAGR of 7% during the forecast period (2024 ...

Bottles of two medications that prevent the body's rejection of transplanted organs were recalled because the capsules may be empty. Astellas Pharma US, Inc. announced this week it is voluntarily ...

In 2022, the adoption of sophisticated empty capsules is anticipated to be valued at US$2.76 billion. By 2032, it is predicted that sales of Advanced Empty Capsule Market will surpass a valuation of ...

Hard Empty Capsule Market is Segmented by Type (Gelatin Capsule, Plant Capsule), by Application (Pharmaceutical, Healthcare Products): Global Opportunity Analysis and Industry Forecast, 2024-2030.

Two drugs have been recalled because their capsules might be empty — and the consequences could be deadly. Astellas Pharma’s Prograf gets prescribed after heart, liver, kidney or lung transplants.